Article Information
History
- November 12, 2019.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Christoph Kraus, MD1,2,*,
- Anahit Mkrtchian, MSc1,3,
- Bashkim Kadriu, MD1,
- Allison C. Nugent, PhD1,4,
- Carlos A. Zarate Jr., MD1 and
- Jennifer W. Evans, PhD1
- 1Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, U.S.A.
- 2Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
- 3Institute of Cognitive Neuroscience, University College London, London, United Kingdom
- 4Magnetoencephalography Core Facility, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland
- ↵*Corresponding Author: christoph.kraus{at}nih.gov
Posted November 12, 2019.
Replicating Global Brain Connectivity as an Imaging Marker for Depression – Influence of Preprocessing Strategies and Randomized Placebo-Controlled Ketamine Treatment
